We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
TE Connectivity Bumps Up Dividend & Increases Share Buyback
Read MoreHide Full Article
TE Connectivity Ltd. (TEL - Free Report) recently announced a hike in dividend along with an increase in its share repurchase program.
This time around, the company approved an increase in its quarterly dividend by a couple of cents to 46 cents per share. This translates into a 4.5% increase from the prior dividend of 44 cents.
In addition, TE Connectivity authorized an increase in its share repurchase program by an additional $1.5 billion.
Impressive Fundamentals Drive Growth
TE Connectivity topped the Zacks Consensus Estimate in all the trailing four quarters, with average of 5.57%.
In the last reported quarter, the company reported non-GAAP earnings of $1.35 per share, which surged 19.5% on a year-over-year basis.
Further, revenues increased 1.5% year over year to $3.51 billion. The top-line growth was driven by solid segmental performance, especially in the Industrial and Communications segments.
TE Connectivity’s strong efforts toward business development will continue to boost segmental performance.
Moreover, aggressive share buyback will fuel its bottom line. For the fiscal first quarter of 2019, the company expects non-GAAP earnings within $1.25-$1.29 per share. Non-GAAP revenues are projected in the range of $3.33-$3.43 billion, reflecting growth of 3% at mid-point.
Cash Flow Generation Remains Strong
We believe that TE Connectivity’s strong balance sheet and cash flow generating ability will support its shareholder-friendly initiatives.
Cash and cash equivalents, short-term investments, along with restricted cash and investment balance totaled $848 million in fourth-quarter fiscal 2018.
Moreover, TE Connectivity generated free cash flow of $922 million in the last reported quarter, up 10% from the year-ago quarter. Further, the company paid back $1.6 billion to its shareholders through share repurchases and dividend payments, and used $153 million for acquisitions.
Long-term earnings growth rate for AMETEK, QuinStreet and Stamps.com is currently pegged at 11.18%, 25% and 15%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
TE Connectivity Bumps Up Dividend & Increases Share Buyback
TE Connectivity Ltd. (TEL - Free Report) recently announced a hike in dividend along with an increase in its share repurchase program.
This time around, the company approved an increase in its quarterly dividend by a couple of cents to 46 cents per share. This translates into a 4.5% increase from the prior dividend of 44 cents.
In addition, TE Connectivity authorized an increase in its share repurchase program by an additional $1.5 billion.
Impressive Fundamentals Drive Growth
TE Connectivity topped the Zacks Consensus Estimate in all the trailing four quarters, with average of 5.57%.
In the last reported quarter, the company reported non-GAAP earnings of $1.35 per share, which surged 19.5% on a year-over-year basis.
Further, revenues increased 1.5% year over year to $3.51 billion. The top-line growth was driven by solid segmental performance, especially in the Industrial and Communications segments.
TE Connectivity’s strong efforts toward business development will continue to boost segmental performance.
Moreover, aggressive share buyback will fuel its bottom line. For the fiscal first quarter of 2019, the company expects non-GAAP earnings within $1.25-$1.29 per share. Non-GAAP revenues are projected in the range of $3.33-$3.43 billion, reflecting growth of 3% at mid-point.
Cash Flow Generation Remains Strong
We believe that TE Connectivity’s strong balance sheet and cash flow generating ability will support its shareholder-friendly initiatives.
Cash and cash equivalents, short-term investments, along with restricted cash and investment balance totaled $848 million in fourth-quarter fiscal 2018.
Moreover, TE Connectivity generated free cash flow of $922 million in the last reported quarter, up 10% from the year-ago quarter. Further, the company paid back $1.6 billion to its shareholders through share repurchases and dividend payments, and used $153 million for acquisitions.
TE Connectivity Ltd. Price and Consensus
TE Connectivity Ltd. Price and Consensus | TE Connectivity Ltd. Quote
Zacks Rank & Stocks to Consider
TE Connectivity currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the broader technology sector include AMETEK, Inc. (AME - Free Report) , QuinStreet, Inc. (QNST - Free Report) and Stamps.com Inc. , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term earnings growth rate for AMETEK, QuinStreet and Stamps.com is currently pegged at 11.18%, 25% and 15%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>